Oncology Business Management | Specialty

Pre-clinical Study Suggests Nab-paclitaxel Plus Bevacizumab May hold Promise for Treating Triple Negative Breast Cancer

June 2nd 2010

According to a pre-clinical study presented at the AACR 101st Annual Meeting 2010, a regimen of nab-paclitaxel (Abraxane) given in combination with bevacizumab (Avastin) may have potential in treating triple-negative breast cancer, one of the most aggressive, therapy- resistant, and highly metastatic subtypes of breast cancer.

NO-Naproxen May Protect Against Colorectal Cancer

June 2nd 2010

A study presented at the AACR 101st Annual Meeting 2010 by researchers from the Fox Chase Cancer Center, Philadelphia, Pennsylvania, provides further evidence that non-steroidal anti-inflammatory drugs (NSAIDs) are promising chemopreventive agents with activity against colorectal cancer.

New Gene Technology Assesses Nine Genes that may Predict Response to Panitumumab

June 2nd 2010

Although KRAS gene mutation is a well-established biomarker for a lack of response to anti-epidermal growth factor receptor (anti-EGFR) antibodies in colorectal cancer, a study presented at the AACR 101st Annual Meeting 2010 sought to determine whether mutations in 9 genes known to be mutated in colorectal cancer, including AKT1, BRAF, CTNNB1, EGFR, KRAS (exon 3), NRAS, PIK3CA, PTEN, and TP53, could also predict response to Vectibix (panitumumab) in patients with metastatic colorectal cancer.

Melanoma: Improving Clinical Outcomes Through Advances in Immunotherapeutics and Targeted Therapy

June 2nd 2010

Metastatic melanoma has limited treatment options, but advances in the understanding of the oncogenic mutations that drive this cancer and how the immune system can be better modulated to fight melanoma provide a new generation of active approaches for patients.

Medication Adherence Technologies: Promise or Pitfalls?

June 2nd 2010

Historically, most cancer treatments have been administered in oncology offices or hospitals, but oral medications are becoming increasingly common, and oral formulations of chemotherapy, targeted therapies, and hormonal therapies are available.

WebMD Health Exchange Seeks to Connect Patients

June 2nd 2010

The explosive growth of mainstream social networking sites has encouraged the development of smaller, niche networks designed to connect patients who share a diagnosis; however, no one platform has established itself as a central health-networking hub.

MedWatch Offers Safety Alerts via Text

June 2nd 2010

The FDA has added text messaging to the ranks of e-mail digests, RSS feeds, podcasts, and Websites that comprise MedWatch, the agency's safety information and adverse event reporting program.

Life Beyond Cancer Foundation Launches New Online Resource

June 2nd 2010

The Life Beyond Cancer Foundation, formerly known as the US Oncology Foundation, has launched its new Website.

Tech Coalition Targets Stone Age Privacy Laws

June 2nd 2010

Enacted in 1986, the Electronic Communications Privacy Act (ECPA) was designed to protect the electronic documents of private citizens from undue interference by law enforcement officials.

Cancer fundraising gone too far?

June 2nd 2010

Susan G. Komen for the Cure's partnership with KFC to raise funds and spread breast cancer awareness and educational messaging by selling chicken in specially designed pink buckets has generated considerable controversy, with some wondering what message this partnership is sending.

FDA Approves First Immunotherapy Vaccine for Cancer

June 2nd 2010

Provenge, an immunotherapy for patients with advanced prostate cancer, has become the first therapeutic vaccine for cancer ever approved by the FDA.

ASCO Meeting Highlights

May 28th 2010

The American Society of Clinical Oncology (ASCO) held its 44th Annual Clinical Meeting in Chicago. Leading oncologists and cancer researchers at centers from around the world presented new basic and clinical research findings to advance the care of cancer.

ASCO Coverage for Community Physicians

May 28th 2010

This issue of Oncology & Biotech News presents significant sessions and posters from the 44th annual meeting of the American Society of Clinical Oncology (ASCO) plus stories on drive-through breast cancer surgery centers, cancer patients' out-of-pocket costs, and more.

Clinical Trial Reports: May 28, 2010

May 28th 2010

Reimbursement and Managed Care News: May 28, 2010

May 28th 2010

Clinical Abstracts From Overseas: May 26, 2010

May 26th 2010

Study Shows Benefit in Prostate Cancer Surgery

May 26th 2010

According to a randomized controlled trial, men with early prostate cancer who have their prostate glands surgically removed are less likely to die from the disease than those who take a wait-and-see approach.

Biomarker Discoveries Bring New Choices and Challenges

May 26th 2010

The ability to predict how the course of cancer will likely play out in an individual patient based on genetic factors is already changing the way certain cancers are approached. As highlighted at the recent Biomarker World Conference in Philadelphia, clinical oncologists have an increasingly integral role.

Biomarker World Congress Highlights New Opportunities for Clinical Oncologists

May 26th 2010

This year's Biomarker World Conference in Philadelphia heralded exciting new advances in cancer care and emphasized the opportunities and challenges facing oncologists seeking to integrate these new predictive tools into practice.

The Academy: May 26, 2010

May 26th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.